Edition:
United Kingdom

Bellerophon Therapeutics Inc (BLPH.OQ)

BLPH.OQ on NASDAQ Stock Exchange Global Market

0.65USD
19 Jul 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.65
Open
$0.71
Day's High
$0.74
Day's Low
$0.63
Volume
51,699
Avg. Vol
47,833
52-wk High
$2.76
52-wk Low
$0.47

About

Bellerophon Therapeutics, Inc. is a clinical-stage therapeutics company. The Company is focused on developing products at the intersection of drugs and devices that address medical needs in the treatment of cardiopulmonary diseases. The Company is focused on the development of its nitric oxide therapy for patients with pulmonary... (more)

Overall

Beta: --
Market Cap(Mil.): $55.04
Shares Outstanding(Mil.): 35.51
Dividend: --
Yield (%): --

Financials

  BLPH.OQ Industry Sector
P/E (TTM): -- 69.41 32.67
EPS (TTM): -1.39 -- --
ROI: -187.88 8.94 14.49
ROE: -359.90 10.07 15.79

Earnings vs. Estimates